期刊文献+

药师参与严重腹腔感染患者的会诊与药学监护 被引量:1

Pharmaceutical Consultation and Care on One Patient with Severe Abdominal Infection
下载PDF
导出
摘要 患者1年前吞入刀片,在我院行剖腹探查术,术中见肠管破裂穿孔,行"结肠异物取出术+部分小肠、结肠切除术"。术后抗感染治疗4天后自动出院。出院后发热,患者再次入住普外科。腹腔脓液、分泌物培养示大肠埃希菌、肺炎克雷伯菌、粪肠球菌、奇异变形杆菌以及星座链球菌等多种细菌,患者所用药物疗效不佳,临床药师先后两次参加会诊,根据药敏结果和患者病情,建议改用美罗培南联合万古霉素抗感染,临床采纳。治疗期间,药师关注患者用药后各项指标变化。经治疗,患者体温、血常规、C反应蛋白等感染指标逐渐恢复正常,病情得到控制。 One 32-year male patient was admitted to our hospital because of abdominal pain for eight days and intestinal perforation rupture after five days. The patient swallowed a blade one year ago. He un-derwent laparotomy on 09-13 and took colectomy for ruptured bowel perforation. He admitted anti-infection treatment for 4 days and left the hospital. After discharge, the patient got a fever and came back on 09-19. The culture of abdominal pus and secretions showed escherichia coli, klebsiella pneumoniae, enterococ-cus faecalis, proteus mirabilis and streptococcus constellatus. The clinical pharmacists gave pharmacy con-sultation two times, advising the doctor to give the patient meropenem combined with vancomycin for thera-py according to the bacterial culture. The pharmacists gave the patient pharmaceutical care based on the changes of the infectious indicators. After the therapy, the patient's body temperature, blood test and C-re-active protein gradually returned to normal. These indicated that the infection became under control.
出处 《药学与临床研究》 2014年第5期446-449,共4页 Pharmaceutical and Clinical Research
关键词 腹腔感染 临床药师 药学会诊 药学监护 Abdominal infection Clinical pharmacist Pharmaceutical consultation Pharmaceutical care
  • 相关文献

参考文献8

  • 1Hoban D J, Bouchillon SK, Hawser SP, et al. Trends in the frequency of multiple drug-resistant Enterobacteri- aceae and their susceptibility to ertapenem, imipenem, and other antimicrobial agents: data from the Study for Monitoring Antimicrobial Resistance Trends 2002 to 2007[J]. Diagn Microbiol Infect Dis, 2010, 66(1): 78-86.
  • 2吕媛,王珊.卫生部全国细菌耐药监测网2011年度肠杆菌科细菌耐药监测[J].中国临床药理学杂志,2012,28(12):937-940. 被引量:40
  • 3Pournaras S, Protonotariou E, Voulgari E, et al. Clonal spread of KPC-2 carbapenemase-produeing Klebsiella pneumoniae strains in Greece[J]. J Antimicrob Chemother, 2009, 64(2): 348-52.
  • 4<应用抗菌药物防治外科感染的指导意见>撰写协作组.应用抗菌药物防治外科感染的指导意见(草案)Ⅲ[J].中国实用外科杂志,2003,23(8). 被引量:6
  • 5Hawser SP, Bouchillon SK, Hoban D J, et al. In vitro susceptibilities of aerobic and facultative anaerobic Gram -negative bacilli from patients with intra - abdominal infections worldwide from 2005-2007: resrlts from the SMART study [J]. Int J Antimicrob Agents, 2009, 34(6): 585-8.
  • 6Hawser SP, Bouchillon SK, Hoban D J, et al. Emer- gence of high levels of extended-spectrum 13-lacta- mase-producing Gram-negative bacilli in the asia-pa- cific region: data from the study for Monitoring Antimi- crobial Resistance Trends (SMART) Program, 2007[J]. Antimicrob Agents Chemother, 2009, 53(8): 3280-4.
  • 7产超广谱β-内酰胺酶细菌感染防治专家共识[J].中华实验和临床感染病杂志(电子版),2010,4(2):51-54. 被引量:134
  • 8黄晓群.产AmpC酶和ESBLs的大肠埃希菌药敏分析[J].海南医学,2009,20(10):126-127. 被引量:5

二级参考文献21

共引文献179

同被引文献9

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部